CeQur announced today that it closed an oversubscribed equity financing round with proceeds of $115 million.
Lucerne, Switzerland/Marlborough, Mass.-based CeQur said in a news release that it plans to use the funds to advance the commercial plans for the CeQur Simplicity wearable insulin delivery device. The company’s plans include market development, a phased commercial launch with a limited market release in 2021 and the scale-up of high-volume manufacturing.
Get the full story at our sister site, Drug Delivery Business News.
"device" - Google News
April 14, 2021 at 02:07AM
https://ift.tt/3e4RQCD
CeQur raises $115M for wearable insulin delivery device - Mass Device
"device" - Google News
https://ift.tt/2KSbrrl
https://ift.tt/2YsSbsy
Bagikan Berita Ini
Related Posts :
7.81% CAGR in Medical Device Manufacturing Outsourcing Market from 2021 to 2025|Technavio - KPVI News 6- Facebook Portal Plus review: A decent video-chat device marred by its maker - CNET
- Federal Health Care Organizations Seek New Prescription for Managing Device Vulnerability - Nextgov
- Facebook Portal Go review: A great portable video calling screen marred by the company’s privacy and trust issues - CNBC
- A ray gun-like device helps scientists see plants in a different light - CNN
0 Response to "CeQur raises $115M for wearable insulin delivery device - Mass Device"
Post a Comment